Highland Capital Management »

Halozyme Therapeutics shares owned by Highland Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Highland Capital Management from 13F filings

Historical chart of Highland Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Highland Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Highland Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $972k 15k 64.63

More positions owned by Highland Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
iShares S&P 500 Index (IVV)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Costco Wholesale Corporation (COST)
Goldman Sachs (GS)
Merck & Co (MRK)
Facebook Inc cl a (META)
Citigroup (C)

View all positions for Highland Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics